Thanks Longreach. Another thing - John McCutcheon stressed FDA approval is no longer a binary risk, meaning any risk is “temporal”. But even if FDA approval becomes delayed, JM gave me a strong impression that Runway Capital (their lenders) would back them all the way. EBR Systems will succeed! It was good to chat with JM and feel his confidence.
Ann: EBR Systems Investor Roadshow, page-15
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.020(2.00%) |
Mkt cap ! $361.7M | |||
| Open | High | Low | Value | Volume |
| 97.5¢ | 98.5¢ | 96.0¢ | $65.53K | 67.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2334 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 7208 | 2 |
View Market Depth
| Last trade - 13.23pm 05/11/2024 (20 minute delay) ? |
| EBR (ASX) Chart |